Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1999 1
2000 2
2001 3
2002 3
2003 3
2004 3
2005 2
2006 2
2007 1
2008 2
2009 4
2010 9
2011 2
2012 4
2013 12
2014 11
2015 6
2016 3
2017 4
2018 7
2019 10
2020 3
2021 3
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Novel Allosteric Modulators of G Protein-coupled Receptors.
Gentry PR, Sexton PM, Christopoulos A. Gentry PR, et al. J Biol Chem. 2015 Aug 7;290(32):19478-88. doi: 10.1074/jbc.R115.662759. Epub 2015 Jun 22. J Biol Chem. 2015. PMID: 26100627 Free PMC article. Review.
Drugs for allosteric sites on receptors.
Wenthur CJ, Gentry PR, Mathews TP, Lindsley CW. Wenthur CJ, et al. Among authors: gentry pr. Annu Rev Pharmacol Toxicol. 2014;54:165-84. doi: 10.1146/annurev-pharmtox-010611-134525. Epub 2013 Oct 2. Annu Rev Pharmacol Toxicol. 2014. PMID: 24111540 Free PMC article. Review.
Formaldehyde, Hematotoxicity, and Chromosomal Changes-Letter.
Mundt KA, Gallagher AE, Dell LD, Natelson E, Boffetta P, Gentry PR. Mundt KA, et al. Among authors: gentry pr. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):119. doi: 10.1158/1055-9965.EPI-17-0306. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29311166 No abstract available.
Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop.
Andersen ME, Gentry PR, Swenberg JA, Mundt KA, White KW, Thompson C, Bus J, Sherman JH, Greim H, Bolt H, Marsh GM, Checkoway H, Coggon D, Clewell HJ 3rd. Andersen ME, et al. Among authors: gentry pr. Regul Toxicol Pharmacol. 2019 Aug;106:210-223. doi: 10.1016/j.yrtph.2019.04.015. Epub 2019 May 3. Regul Toxicol Pharmacol. 2019. PMID: 31059732 Free article. Review.
Development of a Novel, Orthosteric M5 Antagonist Possessing a High Degree of Muscarinic Subtype Selectivity.
Gentry PR, Kokubo M, Bridges TM, Daniels JS, Niswender CM, Smith E, Chase P, Hodder PS, Rosen H, Conn PJ, Engers J, Brewer KA, Wood MR, Lindsley CW. Gentry PR, et al. 2013 Dec 15 [updated 2015 Feb 11]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2013 Dec 15 [updated 2015 Feb 11]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 25834910 Free Books & Documents. Review.
Development of the First Potent, Selective and CNS penetrant M5 Negative Allosteric Modulator (NAM).
Gentry PR, Kokubo M, Bridges TM, Daniels JS, Niswender CM, Smith E, Chase P, Hodder PS, Rosen H, Conn PJ, Engers J, Brewer KA, Wood MR, Lindsley CW. Gentry PR, et al. 2013 Dec 9 [updated 2014 Sep 18]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. 2013 Dec 9 [updated 2014 Sep 18]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010–. PMID: 25506971 Free Books & Documents. Review.
92 results